Equities Analysts Issue Forecasts for LifeStance Health Group, Inc.'s Q1 2023 Earnings (NASDAQ:LFST)
Equities Analysts Issue Forecasts for LifeStance Health Group, Inc.'s Q1 2023 Earnings (NASDAQ:LFST)
LifeStance Health Group, Inc. (NASDAQ:LFST – Get Rating) – Research analysts at William Blair lowered their Q1 2023 earnings per share (EPS) estimates for LifeStance Health Group in a note issued to investors on Wednesday, February 1st. William Blair analyst R. Daniels now expects that the company will post earnings per share of ($0.13) for the quarter, down from their prior forecast of ($0.12). The consensus estimate for LifeStance Health Group's current full-year earnings is ($0.60) per share. William Blair also issued estimates for LifeStance Health Group's Q2 2023 earnings at ($0.12) EPS, Q3 2023 earnings at ($0.11) EPS, Q4 2023 earnings at ($0.10) EPS and FY2023 earnings at ($0.47) EPS.
LifeStance Health Group,Inc.(纳斯达克代码:LFST-GET Rating)-威廉·布莱尔的研究分析师在2月1日星期三发给投资者的一份报告中下调了对LifeStance Health Group 2023年第一季度每股收益(EPS)的预期。威廉·布莱尔分析师R.Daniels现在预计,该公司本季度每股收益将为0.13美元,低于此前预测的0.12美元。对LifeStance Health Group目前全年收益的普遍估计是每股0.60美元。威廉·布莱尔还发布了对LifeStance Health Group 2023年第二季度每股收益(0.12美元)、2023年第三季度每股收益(0.11美元)、2023年第四季度每股收益(0.10美元)和2023财年每股收益(0.47美元)的预期。
LifeStance Health Group (NASDAQ:LFST – Get Rating) last issued its quarterly earnings data on Tuesday, November 8th. The company reported ($0.11) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.15) by $0.04. LifeStance Health Group had a negative return on equity of 18.01% and a negative net margin of 33.77%. The company had revenue of $217.56 million during the quarter, compared to the consensus estimate of $219.69 million.
LifeStance Health Group(纳斯达克:LFST-GET评级)最近一次发布季度收益数据是在11月8日(星期二)。该公司公布本季度每股收益(EPS)为0.11美元,比分析师普遍预期的每股收益(0.15美元)高出0.04美元。LifeStance Health Group的净资产回报率为负18.01%,净利润率为负33.77%。该公司本季度营收为2.1756亿美元,而市场普遍预期为2.1969亿美元。
LifeStance Health Group Price Performance
LifeStance Health Group价格表现
Shares of LFST opened at $5.53 on Monday. LifeStance Health Group has a 1 year low of $4.22 and a 1 year high of $11.25. The company has a debt-to-equity ratio of 0.14, a current ratio of 2.25 and a quick ratio of 2.25. The company has a market capitalization of $2.08 billion, a price-to-earnings ratio of -6.91 and a beta of 0.61. The business has a 50-day moving average of $5.09 and a 200-day moving average of $6.37.
周一,LFST的股价开盘报5.53美元。LifeStance Health Group的一年低点为4.22美元,一年高位为11.25美元。该公司的债务权益比为0.14,流动比率为2.25,速动比率为2.25。该公司市值20.8亿美元,市盈率为-6.91倍,贝塔系数为0.61。该业务的50日移动均线切入位在5.09美元,200日移动均线切入位在6.37美元。
Institutional Investors Weigh In On LifeStance Health Group
机构投资者看好LifeStance Health Group
Hedge funds and other institutional investors have recently modified their holdings of the company. OLD National Bancorp IN bought a new stake in shares of LifeStance Health Group during the fourth quarter valued at approximately $49,000. Dynamic Advisor Solutions LLC bought a new stake in shares of LifeStance Health Group during the fourth quarter valued at approximately $56,000. Ameritas Investment Partners Inc. increased its holdings in shares of LifeStance Health Group by 56.6% during the first quarter. Ameritas Investment Partners Inc. now owns 5,575 shares of the company's stock valued at $56,000 after acquiring an additional 2,016 shares in the last quarter. Point72 Hong Kong Ltd bought a new stake in shares of LifeStance Health Group during the second quarter valued at approximately $63,000. Finally, Price T Rowe Associates Inc. MD purchased a new position in shares of LifeStance Health Group during the third quarter valued at approximately $75,000. Institutional investors own 76.49% of the company's stock.
对冲基金和其他机构投资者最近调整了对该公司的持股。Old National Bancorp IN在第四季度购买了LifeStance Health Group的新股,价值约4.9万美元。Dynamic Advisor Solutions LLC在第四季度购买了LifeStance Health Group的新股,价值约56,000美元。今年第一季度,ameritas Investment Partners Inc.增持的LifeStance Health Group股票增加了56.6%。Ameritas Investment Partners Inc.目前持有该公司5,575股股票,价值56,000美元,该公司在上个季度增持了2,016股股票。Point72 Hong Kong Ltd在第二季度购买了LifeStance Health Group的新股,价值约63,000美元。最后,Price T Rowe Associates Inc.MD在第三季度购买了LifeStance Health Group价值约7.5万美元的新股票头寸。机构投资者持有该公司76.49%的股份。
LifeStance Health Group Company Profile
LifeStance Health Group公司简介
(Get Rating)
(获取评级)
LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.
LifeStance Health Group,Inc.通过其子公司提供门诊精神健康服务。该公司为患者提供一整套精神健康服务,包括精神评估和治疗、心理和神经心理测试,以及个人、家庭和团体治疗。
Read More
阅读更多内容
- Get a free copy of the StockNews.com research report on LifeStance Health Group (LFST)
- MarketBeat Week in Review – 1/30 – 2/3
- Are Penny Stocks Worth it? Should You Invest in Penny Stocks?
- Zimmer Biomet Beats on Earnings, Growth May be Priced In
- AI Software Maker EPAM Boasts Biggest Tech-Sector Rally
- Ford Stock Going Forward After Big Earnings Flop
- 免费获取StockNews.com关于LifeStance Health Group(LFST)的研究报告
- 市场回顾周-1/30-2/3
- 细价股值得吗?你应该投资细价股吗?
- Zimmer Biomet盈利节节攀升,增长可能被计入价格
- 人工智能软件制造商EPAM号称科技板块涨幅最大
- 福特股票在盈利大幅下滑后继续前进
Receive News & Ratings for LifeStance Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeStance Health Group and related companies with MarketBeat.com's FREE daily email newsletter.
接受LifeStance健康集团日报的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收LifeStance Health Group和相关公司的最新新闻和分析师评级的每日摘要。